Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach
Transl Lung Cancer Res
.
2018 Sep;7(Suppl 3):S265-S269.
doi: 10.21037/tlcr.2018.09.10.
Authors
Sharon R Pine
1
2
3
,
Bríd M Ryan
4
Affiliations
1
Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
2
Department of Medicine, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
3
Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
4
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
PMID:
30393619
PMCID:
PMC6193905
DOI:
10.21037/tlcr.2018.09.10
No abstract available
Publication types
Editorial
Comment